-- RB Global Brief: Filing Says Steve Lewis, Co's Chief Operations Officer, Has Assumed Ms. King's Responsibilities On An Interim Basis-March 2024-www.financetom.com

-- RB Global Brief: Filing Says Steve Lewis, Co's Chief Operations Officer, Has Assumed Ms. King's Responsibilities On An Interim Basis

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

-- RB Global Brief: Filing Says Steve Lewis, Co's Chief Operations Officer, Has Assumed Ms. King's Responsibilities On An Interim Basis

Nov 24, 2025 8:19 AM

10:44 AM EST, 11/24/2025 (MT Newswires) --

Price: 135.91, Change: +0.37, Percent Change: +0.27

Previous page： Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial Next page： Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial

Sep 24, 2025

Sept 24 (Reuters) - Harmony Biosciences ( HRMY ) said on Wednesday its experimental drug for a type of rare genetic disorder failed to meet the main goal in a late-stage trial. ...

Freeport-McMoRan expects lower consolidated sales for copper, gold in third quarter

Sep 24, 2025

Sept 24 (Reuters) - Miner Freeport-McMoRan said on Wednesday that it was expecting consolidated sales to be about 4% lower for copper and nearly 6% lower for gold in the third quarter, compared with its prior forecast. (Reporting by Pooja Menon in Bengaluru; Editing by Anil D'Silva) ...

Two US senators urge Tinder parent to act against dating scams on its apps

Sep 24, 2025

(Reuters) -Two U.S. senators sent a letter to Tinder parent Match on Wednesday, pushing for action against dating scams on the company's platforms and asking for information about its efforts to detect frauds and protect its users. In a letter to Match CEO Spencer Rascoff, Democratic Senator Maggie Hassan and Republican Senator Marsha Blackburn asked the company to provide documents...

Biogen Says Leqembi Approved in Australia as Treatment for Alzheimer's Disease; Shares Up Pre-Bell

Sep 24, 2025

08:11 AM EDT, 09/24/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Wednesday that Australia's Therapeutic Goods Administration approved Leqembi for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease. The approval follows a review process after the regulatory agency initially did not approve the drug in February, the company said. Leqembi targets toxic protofibrils and...